These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37952153)

  • 1. Molecular recognition of niacin and lipid-lowering drugs by the human hydroxycarboxylic acid receptor 2.
    Zhu S; Yuan Q; Li X; He X; Shen S; Wang D; Li J; Cheng X; Duan X; Xu HE; Duan J
    Cell Rep; 2023 Nov; 42(11):113406. PubMed ID: 37952153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural insights into ligand recognition and selectivity of the human hydroxycarboxylic acid receptor HCAR2.
    Pan X; Ye F; Ning P; Zhang Z; Li X; Zhang B; Wang Q; Chen G; Gao W; Qiu C; Wu Z; Li J; Zhu L; Xia J; Gong K; Du Y
    Cell Discov; 2023 Nov; 9(1):118. PubMed ID: 38012147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orthosteric ligand selectivity and allosteric probe dependence at Hydroxycarboxylic acid receptor HCAR2.
    Cheng L; Sun S; Wang H; Zhao C; Tian X; Liu Y; Fu P; Shao Z; Chai R; Yan W
    Signal Transduct Target Ther; 2023 Sep; 8(1):364. PubMed ID: 37743365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orthosteric and allosteric modulation of human HCAR2 signaling complex.
    Mao C; Gao M; Zang SK; Zhu Y; Shen DD; Chen LN; Yang L; Wang Z; Zhang H; Wang WW; Shen Q; Lu Y; Ma X; Zhang Y
    Nat Commun; 2023 Nov; 14(1):7620. PubMed ID: 37993467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for ligand recognition and signaling of hydroxy-carboxylic acid receptor 2.
    Park JH; Kawakami K; Ishimoto N; Ikuta T; Ohki M; Ekimoto T; Ikeguchi M; Lee DS; Lee YH; Tame JRH; Inoue A; Park SY
    Nat Commun; 2023 Nov; 14(1):7150. PubMed ID: 37932263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biased allosteric activation of ketone body receptor HCAR2 suppresses inflammation.
    Zhao C; Wang H; Liu Y; Cheng L; Wang B; Tian X; Fu H; Wu C; Li Z; Shen C; Yu J; Yang S; Hu H; Fu P; Ma L; Wang C; Yan W; Shao Z
    Mol Cell; 2023 Sep; 83(17):3171-3187.e7. PubMed ID: 37597514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural insights into the human niacin receptor HCA2-G
    Yang Y; Kang HJ; Gao R; Wang J; Han GW; DiBerto JF; Wu L; Tong J; Qu L; Wu Y; Pileski R; Li X; Zhang XC; Zhao S; Kenakin T; Wang Q; Stevens RC; Peng W; Roth BL; Rao Z; Liu ZJ
    Nat Commun; 2023 Mar; 14(1):1692. PubMed ID: 36973264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of HCAR2 by niacin: benefits beyond lipid lowering.
    Tuteja S
    Pharmacogenomics; 2019 Nov; 20(16):1143-1150. PubMed ID: 31617441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-guided engineering of biased-agonism in the human niacin receptor via single amino acid substitution.
    Yadav MK; Sarma P; Maharana J; Ganguly M; Mishra S; Zaidi N; Dalal A; Singh V; Saha S; Mahajan G; Sharma S; Chami M; Banerjee R; Shukla AK
    Nat Commun; 2024 Mar; 15(1):1939. PubMed ID: 38431681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple recent HCAR2 structures demonstrate a highly dynamic ligand binding and G protein activation mode.
    Shenol A; Tenente R; Lückmann M; Frimurer TM; Schwartz TW
    Nat Commun; 2024 Jun; 15(1):5364. PubMed ID: 38918366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and characterization of GSK256073, a non-flushing hydroxy-carboxylic acid receptor 2 (HCA2) agonist.
    Sprecher D; Maxwell M; Goodman J; White B; Tang CM; Boullay V; de Gouville AC
    Eur J Pharmacol; 2015 Jun; 756():1-7. PubMed ID: 25773497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The niacin receptor HCAR2 modulates microglial response and limits disease progression in a mouse model of Alzheimer's disease.
    Moutinho M; Puntambekar SS; Tsai AP; Coronel I; Lin PB; Casali BT; Martinez P; Oblak AL; Lasagna-Reeves CA; Lamb BT; Landreth GE
    Sci Transl Med; 2022 Mar; 14(637):eabl7634. PubMed ID: 35320002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxycarboxylic Acid Receptor 2, a Pleiotropically Linked Receptor for the Multiple Sclerosis Drug, Monomethyl Fumarate. Possible Implications for the Inflammatory Response.
    Parodi B; Sanna A; Cedola A; Uccelli A; Kerlero de Rosbo N
    Front Immunol; 2021; 12():655212. PubMed ID: 34084164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized, Placebo-Controlled Trial to Assess the Effects of 8 Weeks of Administration of GSK256073, a Selective GPR109A Agonist, on High-Density Lipoprotein Cholesterol in Subjects With Dyslipidemia.
    Olson EJ; Mahar KM; Haws TF; Fossler MJ; Gao F; de Gouville AC; Sprecher DL; Lepore JJ
    Clin Pharmacol Drug Dev; 2019 Oct; 8(7):871-883. PubMed ID: 31268250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pyrazole partial agonists on HCA(2) -mediated flushing and VLDL-triglyceride levels in mice.
    Li Z; Blad CC; van der Sluis RJ; de Vries H; Van Berkel TJ; Ijzerman AP; Hoekstra M
    Br J Pharmacol; 2012 Oct; 167(4):818-25. PubMed ID: 22616721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential tissue and ligand-dependent signaling of GPR109A receptor: implications for anti-atherosclerotic therapeutic potential.
    Gaidarov I; Chen X; Anthony T; Maciejewski-Lenoir D; Liaw C; Unett DJ
    Cell Signal; 2013 Oct; 25(10):2003-16. PubMed ID: 23770183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation and signaling mechanism revealed by GPR119-G
    Qian Y; Wang J; Yang L; Liu Y; Wang L; Liu W; Lin Y; Yang H; Ma L; Ye S; Wu S; Qiao A
    Nat Commun; 2022 Nov; 13(1):7033. PubMed ID: 36396650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Niacin Receptor Agonists: A Promising Strategy for the Treatment of Dyslipidemia.
    Kothawade PB; Thomas AB; Chitlange SS
    Mini Rev Med Chem; 2021; 21(17):2481-2496. PubMed ID: 33550969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare and potentially pathogenic variants in hydroxycarboxylic acid receptor genes identified in breast cancer cases.
    McGuire Sams C; Shepp K; Pugh J; Bishop MR; Merner ND
    BMC Med Genomics; 2021 Dec; 14(1):284. PubMed ID: 34852802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxycarboxylic Acid Receptor 2 Is a Zika Virus Restriction Factor That Can Be Induced by Zika Virus Infection Through the IRE1-XBP1 Pathway.
    Ma X; Luo X; Zhou S; Huang Y; Chen C; Huang C; Shen L; Zhang P; Liu C
    Front Cell Infect Microbiol; 2019; 9():480. PubMed ID: 32039055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.